Overview
- 99 inspections across 96 sites are on record.
- 381 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-27.
At a glance
Inspections
99
Sites
96
Observations
381
Career since
Dec 2012
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Amgen Manufacturing Limited LLC | 27 Apr 2026 | Human Drugs | On file |
| Bausch & Lomb Incorporated | 20 Mar 2026 | Human Drugs | On file |
| Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company | 13 Feb 2026 | Human Drugs | On file |
| Greer Laboratories, Inc. | 12 Dec 2025 | Human Drugs | On file |
| Catalent Greenville Inc | 24 Oct 2025 | Human Drugs | View 483 → |
Sites inspected
Amgen Manufacturing Limited LLCJuncos, United States1 insp.
Bausch & Lomb IncorporatedTampa, United States1 insp.
Bristol-Myers Squibb Holdings Pharma Ltd. Liability CompanyManati, United States1 insp.
Greer Laboratories, Inc.Lenoir, United States1 insp.
Catalent Greenville IncGreenville, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Angela E Glenn5 shared
Nicole E Knowlton4 shared
Ariel Cruz Figueroa3 shared
Raquel Gonzalez Rivera3 shared
Dennis Cantellops Paite3 shared
Scott T Ballard3 shared
Mabany Lizardi2 shared
Megan T Ziegler2 shared
Joan M Cantellops Figueroa2 shared
Haitao Li2 shared
Full investigator report
Get the verbatim findings behind Santos E Camara's 381 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site